Caplin Point Laboratories Share Price
2748.60+0.00 (+5.85%)
+17.31% past 1 Year
Corporate filings & documents
Announcements
Newspaper Publication for Notice of 35th AGM and E-Voting Information
2 weeks agoNewspaper Publication for Notice of 35th AGM and E-Voting Information
2 weeks agoLetter to Shareholders regarding dispatch of 35th AGM Notice and Annual Report for the Financial year 2025-26
2 weeks agoLetter to Shareholders regarding dispatch of 35th AGM Notice and Annual Report for the Financial year 2025-26
2 weeks agoBusiness Responsibility and Sustainability Report for the Financial Year 2025-26
2 weeks agoBusiness Responsibility and Sustainability Report for the Financial Year 2025-26
2 weeks agoNotice of the 35th Annual General Meeting of the Company
2 weeks agoNotice of the 35th Annual General Meeting of the Company
2 weeks agoAnnual Report for the Financial Year 2025-26
2 weeks agoAnnual Report for the Financial Year 2025-26
2 weeks agoNewspaper Publication for convening 35th AGM of the Company through Video Conferencing.
2 weeks agoNewspaper Publication for convening 35th AGM of the Company through Video Conferencing.
2 weeks agoReceipt of Good Manufacturing Practices (GMP) Compliance Certificate by Caplin One Labs Limited (COL) a subsidiary Company from INVIMA
2 weeks agoReceipt of Good Manufacturing Practices (GMP) Compliance Certificate by Caplin One Labs Limited (COL) a subsidiary Company from INVIMA
2 weeks agoCompletion of Unannounced USFDA Inspection at the facility of Caplin Steriles Limited (Companys subsidiary)
1 month agoCompletion of Unannounced USFDA Inspection at the facility of Caplin Steriles Limited (Companys subsidiary)
1 month agoTranscript for Earnings call- Q1- FY 2026-27
1 month agoTranscript for Earnings call- Q1- FY 2026-27
1 month agoAudio Recording of Earnings call for the Quarter ended June 30 2026
1 month agoAudio Recording of Earnings call for the Quarter ended June 30 2026
1 month agoInvestor Presentation for the Earnings Call for the Quarter ended June 30 2026.
1 month agoInvestor Presentation for the Earnings Call for the Quarter ended June 30 2026.
1 month agoThe Board of Director in its meeting held today August 12 2026 approved the appointment of directors.
1 month agoThe Board of Director in its meeting held today August 12 2026 approved the appointment of directors.
1 month agoFinancial Results for the quarter ended June 30 2026
1 month agoFinancial Results for the quarter ended June 30 2026
1 month agoRecord date for Final Dividend is September 18 2026
1 month agoRecord date for Final Dividend is September 18 2026
1 month agoBoard meeting outcome for meeting held on August 12 2026
1 month agoBoard meeting outcome for meeting held on August 12 2026
1 month agoPost-results conference call invite for the quarter ended June 30 2026 is enclosed herewith.
1 month agoPost-results conference call invite for the quarter ended June 30 2026 is enclosed herewith.
1 month agoCaplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. Unaudited financial results of the Company for the Quarter ended June 30 2026 (both Standalone & Consolidated)2. recommendation of Final Dividend if any for the FY 2025-26 and fixation of record date for this purpose.
1 month agoCaplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. Unaudited financial results of the Company for the Quarter ended June 30 2026 (both Standalone & Consolidated)2. recommendation of Final Dividend if any for the FY 2025-26 and fixation of record date for this purpose.
1 month agoIntimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended June 30 2026
2 months agoIntimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended June 30 2026
2 months agoIntimation of closure of Trading Window commencing from July 01 2026
2 months agoIntimation of closure of Trading Window commencing from July 01 2026
2 months agoNewspaper advertisement for transfer of Unclaimed dividend and shares to IEPF
3 months agoNewspaper advertisement for transfer of Unclaimed dividend and shares to IEPF
3 months agoAnnual Secretarial Compliance report for the year ended March 31 2026
3 months agoAnnual Secretarial Compliance report for the year ended March 31 2026
3 months agoIntimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
4 months agoIntimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
4 months agoTranscript for Earnings call- Q4- FY 2025-26
4 months agoTranscript for Earnings call- Q4- FY 2025-26
4 months agoEarnings call for Q4(2025-26)
4 months agoPress release regarding receipt of final approval by our subsidiary Caplin Steriles Limited from USFDA for Foscarnet Sodium Injection
4 months agoThe Board at its meeting held today May 14 2026 had declared Interim Dividend of INR.4.00 (200%) per equity share for the FY 2025-26 and fixed the Record date as May 30 2026.
4 months agoFinancial Results for the Quarter and Year ended March 31 2026
4 months agoConcalls & investor presentations
Aug 2026
May 2026
Feb 2026
Nov 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
Feb 2023
ConcallPresentation
Nov 2022
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Oct 2021
ConcallPresentation
May 2021
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
Nov 2020
ConcallPresentation
Nov 2020
ConcallPresentation